SCHOTT Pharma is a provider of drug containment and delivery solutions for injectables, ranging from prefillable syringes, to cartridges, vials, and ampoules. It manufactures syriQ BioPure® glass prefillable syringes for biologics, and SCHOTT TOPPAC prefillable syringes, made of COP.
SCHOTT Pharma is a provider of drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules.
The company manufactures prefillable syringes, including syriQ BioPure® glass syringes, for highly sensitive formulations, such as biologics, and SCHOTT TOPPAC syringes, which are made of COP. SCHOTT Pharma’s COP offering includes customised containers possible due to the increased design flexibility offered by COP.
The company has more than 1,700 customers including all of the top 30 pharma companies. It is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia. It has around 4,700 staff from over 65 countries, including 130 people working in R&D. It has more than 900 patents and technologies developed in-house.
SCHOTT Pharma AG & Co KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation.